This week, Elizabeth Holmes returns to the stand, presenting herself as a confident CEO with a noble mission who also naively took experts at their word.She meticulously details how she built her business -- even admitting to having doctored those pharmaceutical documents -- but implies over and over again that she relied on information given to her by scientists, doctors and board members to solidify her understanding of where her company stood.Will it be enough to convince a jury that she had no intent to defraud investors? Learn more about your ad choices. Visit megaphone.fm/adchoices